Share this article
Share this article
BEER-SHEVA, Israel, April 8, 2021 /PRNewswire/ Researchers at Ben-Gurion University of the Negev (BGU) have identified novel drug candidates based on molecules isolated from probiotic yogurt for combating pathogenic bacteria and for treating various inflammatory conditions, including inflammatory bowel disease (IBD) and COVID-19 related cytokine storms. The research, led by Ms. Orit Malka, a PhD student in the laboratory of Prof. Raz Jelinek, the Vice President and Dean for Research & Development at BGU, was published in
Microbiome, a leading peer-reviewed publication.
Prof. Raz Jelinek and Ms. Orit Malka with their unique probiotic yogurt at Ben-Gurion University laboratory (Credit: Dani Machlis) (PRNewsfoto/BGN Technologies)
Share this article
Share this article
BEER-SHEVA, Israel, April 8, 2021 /PRNewswire/ Researchers at Ben-Gurion University of the Negev (BGU) have identified novel drug candidates based on molecules isolated from probiotic yogurt for combating pathogenic bacteria and for treating various inflammatory conditions, including inflammatory bowel disease (IBD) and COVID-19 related cytokine storms. The research, led by Ms. Orit Malka, a PhD student in the laboratory of Prof. Raz Jelinek, the Vice President and Dean for Research & Development at BGU, was published in
Microbiome, a leading peer-reviewed publication.
Prof. Raz Jelinek and Ms. Orit Malka with their unique probiotic yogurt at Ben-Gurion University laboratory (Credit: Dani Machlis) (PRNewsfoto/BGN Technologies)
Feb 16, 2021
Israeli researchers developed the first method of its kind to easily monitor the effect of anti-psychotic drugs used to treat schizophrenia.
By TPS
Researchers at Ben-Gurion University of the Negev (BGU) have developed a novel method for instantly and accurately monitoring blood levels of the anti-psychotic drug, clozapine, using a blood drop from a finger prick.
The method, developed by Dr. Hadar Ben-Yoav, Department of Biomedical Engineering and Ilse Katz Institute for Nanoscale Science and Technology, BGU, is based on an electrochemical microsensor which enables, for the first time, clozapine detection in one drop of finger-pricked whole blood samples of schizophrenia patients without using any pretreatment steps.